StockNews.com Upgrades GlaxoSmithKline (NYSE:GSK) to "Strong-Buy" | MarketBeat

Retrieved on: 2022-03-30 05:12:36

Tags for this article:

Finance

Money

Pharmaceutical industry

Click the tags to see associated articles and topics

StockNews.com Upgrades GlaxoSmithKline (NYSE:GSK) to "Strong-Buy" | MarketBeat. View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nyse-gsk-a-buy-or-sell-right-now-2022-03-2-3/

Excerpt

Two Sigma Investments LP now owns 3,457,267 shares of the pharmaceutical company's stock valued at $132,102,000 after acquiring an additional ...

Article found on: www.marketbeat.com

View Original Article